image
Cryo-Cell International, Inc. CCEL
Healthcare - Medical - Care Facilities - NASDAQ - US
Watchlist
$ 4.89
-1.42 %
$ 39.5 M
Market Cap
481.0
P/E
INCOME STATEMENT
32 M REVENUE
2.05%
Growth Rates
1Year 2.05%
3Years 3.46%
5Years 0.11%
7Years 3.36%
10Years 4.74%
3.48 M OPERATING INCOME
128.29%
Growth Rates
1Year 128.29%
3Years -4.56%
5Years -7.22%
7Years -5.06%
10Years 5.80%
402 K NET INCOME
104.22%
Growth Rates
1Year 104.22%
3Years -42.21%
5Years -29.39%
7Years -22.13%
10Years -3.15%
EFFICIENCY
Earnings Waterfall Cryo-Cell International, Inc.
image
Revenue 32 M
Cost Of Revenue 7.95 M
Gross Profit 24 M
Operating Expenses 20.6 M
Operating Income 3.48 M
Other Expenses 3.08 M
Net Income 402 K
35m35m30m30m25m25m20m20m15m15m10m10m5m5m0032m(8m)24m(21m)3m(3m)402kRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Nov-2024 Nov-2023 Nov-2022 Nov-2021 Nov-2020 Nov-2019 Nov-2018 Nov-2017 Nov-2016 Nov-2015 Nov-2014 Nov-2013 Nov-2012 Nov-2011 Nov-2010 Nov-2009 Nov-2008 Nov-2007 Nov-2006 Nov-2005 Nov-2004 Nov-2003 Nov-2002 Nov-2001 Nov-2000 Nov-1999 Nov-1998 Nov-1997 Nov-1996
REVENUE
Revenue 32.0 31.3 30.3 28.9 31.1 31.8 29.2 25.4 23.1 21.1 20.1 19.0 18.0 17.9 17.6 16.3 17.3 17.5 17.2 14.5 12.2 7.5 7.1 5.6 2.1 1.7 0.3 0.4 2.7
GROSS PROFIT
Cost Of Revenue 7.9 8.4 8.8 9.0 9.7 10.0 8.5 6.7 5.8 5.6 5.6 5.3 4.9 4.4 4.5 4.5 6.1 6.6 6.1 4.1 3.2 2.6 2.5 1.7 0.8 0.2 0.2 0 0.3
Gross Profit 24.0 22.9 21.5 19.9 21.5 21.8 20.7 18.7 17.4 15.5 14.5 13.7 13.1 13.5 13.1 11.8 11.2 10.9 11.1 10.3 9.0 4.9 4.6 4.0 1.3 1.5 100 K 0.4 2.4
OPERATING INCOME
Operating Expenses 20.6 35.2 17.1 15.5 14.5 15.1 15.9 13.7 14.9 12.5 12.5 11.6 14.7 13.2 9.9 10.1 11.4 15.5 14.1 9.1 5.9 12.4 10.1 4.5 3.4 2.5 2.5 2.1 1.6
Selling, General and Administrative Expenses 18.5 17.1 15.6 14.6 14.3 14.9 15.6 13.5 14.7 12.4 12.3 11.4 14.4 12.4 9.5 8.9 10.8 14.5 13.0 9.1 6.3 9.7 6.1 4.0 2.9 2.3 1.9 1.8 1.5
Research and Development Expenses 1.2 1.2 0.4 49.9 K 23.9 K 30.1 K 91.8 K 41.2 K 53.1 K 45.8 K 64.4 K 36.2 K 0.1 0.2 0.1 0.1 0.2 0.5 0.5 26.1 K 82.5 K 0.2 0.2 51.1 K 0.3 100 K 0.4 0.2 0
Operating Income 3.5 (12.3) 4.0 4.0 7.7 5.1 5.2 5.0 0.4 2.9 2.0 1.7 (1.7) (0.3) 3.2 1.7 (0.3) (4.7) (3.0) 1.2 3.2 (7.5) (5.5) (0.5) (2.2) (1.0) (2.4) (1.7) 0.8
PRE-TAX INCOME
Interest Income Expense 1.9 1.2 1.5 1.4 1.5 1.7 1.5 1.3 0.9 1.3 1.2 1.4 1.0 1.5 1.3 1.4 1.3 1.4 1.0 0.9 0.8 0.7 58.9 K 10.5 K 2.21 K 0 100 K 0 0
Total Other Income (0.7) (1.1) (0.7) (1.4) (2.6) (1.7) (1.6) (1.4) (2.9) (2.0) (1.3) (1.5) (2.7) (1.6) (1.4) (1.5) (0.3) (0.3) 0.2 (0.1) (0.2) (0.7) (0.3) 0.5 0.6 0.5 0 100 K 100 K
Pre-Tax Income 2.8 (13.4) 3.3 2.6 5.0 3.4 3.6 3.6 (2.5) 0.9 0.7 0.2 (4.4) (1.7) 1.8 1.5 (0.8) (5.0) (2.7) 1.1 3.0 (7.5) (5.2) 0.8 (1.6) (0.5) 0 (1.6) 0.7
NET INCOME
Tax Provision 2.4 (3.8) 0.5 0.5 1.4 1.1 4.5 1.3 (1.2) (7.2) 0.1 0.2 1.9 0.2 (1.6) 0.1 0.5 0.3 (0.1) 36 K 86 K 1.1 K 0.2 (1.4) (0.7) (0.4) 100 K 100 K 0.2
Net Income 0.4 (9.5) 2.8 2.1 3.6 2.3 (0.9) 2.3 (1.3) 8.1 0.6 27.4 K (6.3) (2.1) 3.4 1.4 (0.8) (5.0) (2.8) 1.0 2.8 (7.5) (5.3) 0.9 (1.5) (0.6) (2.3) (1.6) 0.6
EPS 0.05 1.14 0.33 0.26 0.48 0.29 0.11 0.33 0.16 0.85 0.05 0.0025 0.56 0.18 0.29 0.12 0.0649 0.43 0.24 0.09 0.25 0.66 0.47 0.09 0.15 0.0731 0.32 0.23 0.09